Novel isoforms of NADPH-oxidase in cerebral vascular control

Pharmacology and Therapeutics

Volumn 111, Issue 3, 2006, Pages 928-948

  Miller, Alyson A ^a,b   Drummond, Grant R ^b   Sobey, Christopher G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cerebral vascular; Hydrogen peroxide; Hypertension; NADPH oxidase; Superoxide

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ALPHA TOCOPHEROL; AMINOETHYLBENZENESULFONOFLOURIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; APOCYNIN; ASCORBIC ACID; BETA CAROTENE; CHIMERIC PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENYLIODONIUM SALT; FLUORIDE; GLYCOPROTEIN; GP91 DS TAT PROTEIN; HYDROGEN PEROXIDE; MANGANESE DERIVATIVE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); P47PHOX PROTEIN; P67PHOX PROTEIN; PEROXYNITRITE; PLUMBAGIN; PR 39; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STATIN; SUPEROXIDE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ALZHEIMER DISEASE; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; BRAIN ARTERY; CLINICAL TRIAL; HUMAN; HYPERTENSION; METABOLISM; NONHUMAN; PHAGOCYTOSIS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROKE; SUBARACHNOID HEMORRHAGE; VASODILATATION;

ALZHEIMER DISEASE; ANIMALS; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; ISOENZYMES; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; STROKE; SUBARACHNOID HEMORRHAGE; VASODILATION;

EID: 33746689151     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.02.005     Document Type: Review

References (208)

1. Adler S., and Huang H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 287 (2004) F907-F913
2. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
3. Ago T., Kitazono T., Kuroda J., Kumai Y., Kamouchi M., Ooboshi H., et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36 (2005) 1040-1046
4. Alp N.J., and Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24 (2004) 413-420
5. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., and Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279 (2004) 45935-45941
6. Andresen J.J., Faraci F.M., and Heistad D.D. Vasomotor responses in MnSOD-deficient mice. Am J Physiol Heart Circ Physiol 287 (2004) H1141-H1148
7. Arai T., Kelly S.A., Brengman M.L., Takano M., Smith E.H., Goldschmidt-Clermont P.J., et al. Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor alpha in endothelium. Biochem J 331 Pt 3 (1998) 853-861
8. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397 (2002) 342-344
9. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276 (2001) 37594-37601
10. Banfi B., Clark R.A., Steger K., and Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278 (2003) 3510-3513
11. Baumbach G.L., Sigmund C.D., and Faraci F.M. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41 (2003) 50-55
12. Baumbach G.L., Sigmund C.D., and Faraci F.M. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase. Circ Res 95 (2004) 822-829
13. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
14. Bianca V.D., Dusi S., Bianchini E., Dal Pra I., and Rossi F. Beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274 (1999) 15493-15499
15. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277 (2002) 17415-17427
16. + channels in rat cerebral artery smooth muscle cells. Am J Physiol Heart Circ Physiol 278 (2000) H1883-H1890
17. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 68 1 (2005) 26-36
18. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96 (2005) 818-822
19. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
20. Castier Y., Brandes R.P., Leseche G., Tedgui A., and Lehoux S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 97 (2005) 533-540
21. Chabrashvili T., Tojo A., Onozato M.L., Kitiyakara C., Quinn M.T., Fujita T., et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39 (2002) 269-274
22. Chabrashvili T., Kitiyakara C., Blau J., Karber A., Aslam S., Welch W.J., et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285 (2003) R117-R124
23. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21 (2001) 2-14
24. Chan Y.R., Zanetti M., Gennaro R., and Gallo R.L. Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39. J Invest Dermatol 116 (2001) 230-235
25. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 (2001) 606-611
26. Chen J., He J., Hamm L., Batuman V., and Whelton P.K. Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 40 (2002) 810-816
27. Cheng G., and Lambeth J.D. Alternative mRNA splice forms of NOXO1, differential tissue expression and regulation of Nox1 and Nox3. Gene 356 (2005) 118-126
28. Cheng G., Cao Z., Xu X., van Meir E.G., and Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269 (2001) 131-140
29. 2+ sparks and transient KCa currents in smooth muscle cells of rat cerebral arteries. J Physiol 556 (2004) 755-771
30. 2+ Spark Activation. Am J Physiol Cell Physiol 290 (2006) C964-C971
31. + in hypertensive rats. Hypertension 39 (2002) 880-885
32. Chu Y., Alwahdani A., Iida S., Lund D.D., Faraci F.M., and Heistad D.D. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 112 (2005) 1047-1053
33. Cosentino F., Sill J.C., and Katusic Z.S. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 23 (1994) 229-235
34. Crack P.J., and Taylor J.M. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38 (2005) 1433-1444
35. Decoursey T.E., and Ligeti E. Regulation and termination of NADPH oxidase activity. Cell Mol Life Sci 62 (2005) 2173-2193
36. De Deken X., Wang D., Many M.C., Costagliola S., Libert F., Vassart G., et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275 (2000) 23227-23233
37. De Keulenaer G.W., Chappell D.C., Ishizaka N., Nerem R.M., Alexander R.W., and Griendling K.K. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 82 (1998) 1094-1101
38. Diatchuk V., Lotan O., Koshkin V., Wikstroem P., and Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272 (1997) 13292-13301
39. Didion S.P., and Faraci F.M. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol 282 (2002) H688-H695
40. Didion S.P., and Faraci F.M. Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles. Stroke 34 (2003) 2038-2042
41. Didion S.P., Hathaway C.A., and Faraci F.M. Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am J Physiol Heart Circ Physiol 281 (2001) H1697-H1703
42. Didion S.P., Ryan M.J., Didion L.A., Fegan P.E., Sigmund C.D., and Faraci F.M. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res 91 (2002) 938-944
43. Ding Y., Chen Z.J., Liu S., Che D., Vetter M., and Chang C.H. Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone. J Pharm Pharmacol 57 (2005) 111-116
44. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 (1999) 391-397
45. Drummond G.R., Cai H., Davis M.E., Ramasamy S., and Harrison D.G. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86 (2000) 347-354
46. Dusi S., Donini M., and Rossi F. Mechanisms of NADPH oxidase activation: translocation of p40phox, Rac1 and Rac2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox. Biochem J 314 Pt 2 (1996) 409-412
47. Elliott S.J., Lacey D.J., Chilian W.M., and Brzezinska A.K. Peroxynitrite is a contractile agonist of cerebral artery smooth muscle cells. Am J Physiol 275 (1998) H1585-H1591
48. Ellis E.F., Police R.J., Yancey L., McKinney J.S., and Amruthesh S.C. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 259 (1990) H1171-H1177
49. Ellmark S.H., Dusting G.J., Fui M.N., Guzzo-Pernell N., and Drummond G.R. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res 65 (2005) 495-504
50. Engels F., Renirie B.F., Hart B.A., Labadie R.P., and Nijkamp F.P. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 305 (1992) 254-256
51. Fagan S.C., Hess D.C., Hohnadel E.J., Pollock D.M., and Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 35 (2004) 2220-2225
52. Faraci F.M. Oxidative stress: the curse that underlies cerebral vascular dysfunction?. Stroke 36 (2005) 186-188
53. Faraci F.M., and Didion S.P. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24 (2004) 1367-1373
54. Faraci F.M., and Heistad D.D. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66 (1990) 8-17
55. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 (1998) 53-97
56. Faraci F.M., Lamping K.G., Modrick M.L., Ryan M.J., Sigmund C.D., and Didion S.P. Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab (2005)
57. Faraci F.M., Lamping K.G., Modrick M.L., Ryan M.J., Sigmund C.D., and Didion S.P. Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab 26 (2006) 449-455
58. Gillibert M., Dehry Z., Terrier M., El Benna J., and Lederer F. Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation. Biochem J 386 (2005) 549-556
59. Ginis I., Hallenbeck J.M., Liu J., Spatz M., Jaiswal R., and Shohami E. Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Mol Med 6 (2000) 1028-1041
60. Girouard H., and Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100 (2006) 328-335
61. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87 (2000) 26-32
62. Green S.P., Cairns B., Rae J., Errett-Baroncini C., Hongo J.A., Erickson R.W., et al. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab 21 (2001) 374-384
63. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
64. Griendling K.K., Sorescu D., Lassegue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20 (2000) 2175-2183
65. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102 (2000) 1744-1747
66. Hanna I.R., Hilenski L.L., Dikalova A., Taniyama Y., Dikalov S., Lyle A., et al. Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 37 (2004) 1542-1549
67. He S., and Xie H. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors. Asian Pac J Allergy Immunol 22 (2004) 205-212
68. Heyworth P.G., Knaus U.G., Xu X., Uhlinger D.J., Conroy L., Bokoch G.M., et al. Requirement for posttranslational processing of Rac GTP-binding proteins for activation of human neutrophil NADPH oxidase. Mol Biol Cell 4 (1993) 261-269
69. Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., and Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24 (2004) 677-683
70. Howard A.B., Alexander R.W., Nerem R.M., Griendling K.K., and Taylor W.R. Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol 272 (1997) C421-C427
71. Huang J., Agus D.B., Winfree C.J., Kiss S., Mack W.J., McTaggart R.A., et al. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A 98 (2001) 11720-11724
72. Hwang J., Ing M.H., Salazar A., Lassegue B., Griendling K., Navab M., et al. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res 93 (2003) 1225-1232
73. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 (2004) 347-360
74. Iadecola C., Zhang F., Niwa K., Eckman C., Turner S.K., Fischer E., et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2 (1999) 157-161
75. Ido Y., Chang K., Woolsey T.A., and Williamson J.R. NADH: sensor of blood flow need in brain, muscle, and other tissues. FASEB J 15 (2001) 1419-1421
76. Iida Y., and Katusic Z.S. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 31 (2000) 2224-2230
77. Ishizaka N., Griendling K.K., Lassegue B., and Alexander R.W. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32 (1998) 459-466
78. Ishikawa M., Stokes K.Y., Zhang J.H., Nanda A., and Granger D.N. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ Res 94 (2004) 239-244
79. Ito D., Murata M., Watanabe K., Yoshida T., Saito I., Tanahashi N., et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31 (2000) 936-939
80. Jiang F., Guo Y., Salvemini D., and Dusting G.J. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br J Pharmacol 139 (2003) 1127-1134
81. Johansson B.B. Hypertension mechanisms causing stroke. Clin Exp Pharmacol Physiol 26 (1999) 563-565
82. Kamii H., Kato I., Kinouchi H., Chan P.H., Epstein C.J., Akabane A., et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 30 (1999) 867-871
83. Kawahara T., Ritsick D., Cheng G., and Lambeth J.D. Point Mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 280 (2005) 31859-31869
84. Kazama K., Anrather J., Zhou P., Girouard H., Frys K., Milner T.A., et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95 (2004) 1019-1026
85. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
86. Kim D.E., Suh Y.S., Lee M.S., Kim K.Y., Lee J.H., Lee H.S., et al. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 33 (2002) 2687-2691
87. King M.A., Halicka H.D., and Darzynkiewicz Z. Pro- and anti-apoptotic effects of an inhibitor of chymotrypsin-like serine proteases. Cell Cycle 3 (2004) 1566-1571
88. Kinouchi H., Epstein C.J., Mizui T., Carlson E., Chen S.F., and Chan P.H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A 88 (1991) 11158-11162
89. Kitazono T., Faraci F.M., and Heistad D.D. l-arginine restores dilator responses of the basilar artery to acetylcholine during chronic hypertension. Hypertension 27 (1996) 893-896
90. Kobayashi S., Nojima Y., Shibuya M., and Maru Y. Nox1 regulates apoptosis and potentially stimulates branching morphogenesis in sinusoidal endothelial cells. Exp Cell Res 300 (2004) 455-462
91. Kontos H.A., Wei E.P., Povlishock J.T., and Christman C.W. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 55 (1984) 295-303
92. Kontos H.A., Wei E.P., and Marshall J.J. In vivo bioassay of endothelium-derived relaxing factor. Am J Physiol 255 (1988) H1259-H1262
93. Kontos H.A., Wei E.P., Kukreja R.C., Ellis E.F., and Hess M.L. Differences in endothelium-dependent cerebral dilation by bradykinin and acetylcholine. Am J Physiol 258 (1990) H1261-H1266
94. Kontos C.D., Wei E.P., Williams J.I., Kontos H.A., and Povlishock J.T. Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo. Am J Physiol 263 (1992) H1234-H1242
95. Kuribayashi F., Nunoi H., Wakamatsu K., Tsunawaki S., Sato K., Ito T., et al. The adaptor protein p40(phox) as a positive regulator of the superoxide-producing phagocyte oxidase. EMBO J 21 (2002) 6312-6320
96. Kwong C.H., Malech H.L., Rotrosen D., and Leto T.L. Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins. Biochemistry 32 (1993) 5711-5717
97. Lacza Z., Puskar M., Kis B., Perciaccante J.V., Miller A.W., and Busija D.W. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol 283 (2002) H406-H411
98. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4 (2004) 181-189
99. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
100. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (2003) 1201-1209
101. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-R297
102. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88 (2001) 888-894
103. Laude K., Cai H., Fink B., Hoch N., Weber D.S., McCann L., et al. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol 288 (2005) H7-H12
104. 2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol 258 (1990) H1382-H1387
105. Leusen J.H., Verhoeven A.J., and Roos D. Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family. Front Biosci 1 (1996) d72-d90
106. Li J.M., and Shah A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277 (2002) 19952-19960
107. Li J.M., and Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287 (2004) R1014-R1030
108. Li J., Li W., Su J., Liu W., Altura B.T., and Altura B.M. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes. Brain Res Bull 62 (2003) 101-106
109. Li L., Fink G.D., Watts S.W., Northcott C.A., Galligan J.J., Pagano P.J., et al. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107 (2003) 1053-1058
110. Li J., Li W., Altura B.T., and Altura B.M. Peroxynitrite-induced relaxation in isolated canine cerebral arteries and mechanisms of action. Toxicol Appl Pharmacol 196 (2004) 176-182
111. Liu T.H., Beckman J.S., Freeman B.A., Hogan E.L., and Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 256 (1989) H589-H593
112. Liu P., Ying Y., Ko Y.G., and Anderson R.G. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271 (1996) 10299-10303
113. Lopes L.R., Dagher M.C., Gutierrez A., Young B., Bouin A.P., Fuchs A., et al. Phosphorylated p40PHOX as a negative regulator of NADPH oxidase. Biochemistry 43 (2004) 3723-3730
114. Marshall J.J., Wei E.P., and Kontos H.A. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol 255 (1988) H847-H854
115. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., and Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18 (2006) 69-82
116. Mata-Greenwood E., Grobe A., Kumar S., Noskina Y., and Black S.M. Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-beta1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am J Physiol Lung Cell Mol Physiol 289 (2005) L288-L289
117. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106 (2000) 1521-1530
118. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., et al. Nox1 is involved in angiotensin II-mediated hypertension. A study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
119. Mayhan W.G. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol 259 (1990) H1455-H1462
120. Mayhan W.G. Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol 262 (1992) H539-H543
121. Mayhan W.G., Faraci F.M., and Heistad D.D. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol 253 (1987) H1435-H1440
122. McCarthy D.A., and Macey M.G. Novel anticoagulants for flow cytometric analysis of live leucocytes in whole blood. Cytometry 23 (1996) 196-204
123. Miller A.A., Drummond G.R., Schmidt H.H.H.W., and Sobey C.G. NADPH-oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 97 (2005) 1055-1062
124. Miller A.A., Drummond G.R., and Sobey C.G. Selective inhibition of NADPH-oxidase isoforms as a therapeutic strategy in hypertension. Drug Discov Today Ther Strateg 2 (2005) 187-192
125. Miura H., Bosnjak J.J., Ning G., Saito T., Miura M., and Gutterman D.D. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92 (2003) e31-e40
126. Mohazzab K.M., Kaminski P.M., and Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266 (1994) H2568-H2572
127. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90 (2002) E58-E65
128. Morawietz H., Weber M., Rueckschloss U., Lauer N., Hacker A., and Kojda G. Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. Biochem Biophys Res Commun 285 (2001) 1130-1135
129. Morris J.C. Dementia update 2005. Alzheimer Dis Assoc Disord 19 (2005) 100-117
130. MRC/BHF. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 23-33
131. Mullan B.A., Young I.S., Fee H., and McCance D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40 (2002) 804-809
132. Napoli C., Witztum J.L., de Nigris F., Palumbo G., D'Armiento F.P., and Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 99 (1999) 2003-2010
133. Nauseef W.M. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 122 (2004) 277-291
134. Nelson C.W., Wei E.P., Povlishock J.T., Kontos H.A., and Moskowitz M.A. Oxygen radicals in cerebral ischemia. Am J Physiol 263 (1992) H1356-H1362
135. Niwa K., Carlson G.A., and Iadecola C. Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 20 (2000) 1659-1668
136. Niwa K., Younkin L., Ebeling C., Turner S.K., Westaway D., Younkin S., et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A 97 (2000) 9735-9740
137. Niwa K., Haensel C., Ross M.E., and Iadecola C. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88 (2001) 600-608
138. Niwa K., Porter V.A., Kazama K., Cornfield D., Carlson G.A., and Iadecola C. A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 281 (2001) H2417-H2424
139. Niwa K., Kazama K., Younkin L., Younkin S.G., Carlson G.A., and Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283 (2002) H315-H323
140. Ospina J.A., Duckles S.P., and Krause D.N. 17beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol 285 (2003) H241-H250
141. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 94 (1997) 14483-14488
142. Paravicini T.M., and Sobey C.G. Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidase. Clin Exp Pharmacol Physiol 30 (2003) 855-859
143. Paravicini T.M., Gulluyan L.M., Dusting G.J., and Drummond G.R. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ Res 91 (2002) 54-61
144. Paravicini T.M., Chrissobolis S., Drummond G.R., and Sobey C.G. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 35 (2004) 584-589
145. Paravicini, T. M., Miller, A. A., Drummond, G. R., & Sobey, C. G. (in press). Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol 3-kinase (PI3-K), NADPH-oxidase, and Nitric Oxide Synthase. J Cereb Blood Flow Metab.
146. Park J.W., Hoyal C.R., Benna J.E., and Babior B.M. Kinase-dependent activation of the leukocyte NADPH oxidase in a cell-free system. Phosphorylation of membranes and p47(PHOX) during oxidase activation. J Biol Chem 272 (1997) 11035-11043
147. 2. Mol Cell Biol 24 (2004) 4384-4394
148. Park L., Anrather J., Forster C., Kazama K., Carlson G.A., and Iadecola C. Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex. J Cereb Blood Flow Metab 24 (2004) 334-342
149. Park L., Anrather J., Zhou P., Frys K., Wang G., and Iadecola C. Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol 24 (2004) 1860-1865
150. Park L., Anrather J., Zhou P., Frys K., Pitstick R., Younkin S., et al. NADPH oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25 (2005) 1769-1777
151. Poulter N. Global risk of cardiovascular disease. Heart 89 Suppl. 2 (2003) ii2-ii5 (discussion ii35-37)
152. Pueyo M.E., Gonzalez W., Nicoletti A., Savoie F., Arnal J.F., and Michel J.B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20 (2000) 645-651
153. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
154. - and systolic blood pressure in mice. Circ Res 89 (2001) 408-414
155. Rodriguez-Iturbe B., Zhan C.D., Quiroz Y., Sindhu R.K., and Vaziri N.D. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41 (2003) 341-346
156. Rosenblum W.I. Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke 17 (1986) 494-497
157. Rosenblum W.I. Hydroxyl radical mediates the endothelium-dependent relaxation produced by bradykinin in mouse cerebral arterioles. Circ Res 61 (1987) 601-603
158. Ruiz-Gines J.A., Lopez-Ongil S., Gonzalez-Rubio M., Gonzalez-Santiago L., Rodriguez-Puyol M., and Rodriguez-Puyol D. Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol 35 (2000) 109-113
159. Sakaki S., Kuwabara H., and Ohta S. Biological defence mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms. Stroke 17 (1986) 196-202
160. Sankarapandi S., Zweier J.L., Mukherjee G., Quinn M.T., and Huso D.L. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch Biochem Biophys 353 (1998) 312-321
161. Shi J., Ross C.R., Leto T.L., and Blecha F. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc Natl Acad Sci U S A 93 (1996) 6014-6018
162. Shimohama S., Tanino H., Kawakami N., Okamura N., Kodama H., Yamaguchi T., et al. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273 (2000) 5-9
163. Shin H.K., Lee J.H., Kim K.Y., Kim C.D., Lee W.S., Rhim B.Y., et al. Impairment of autoregulatory vasodilation by NAD(P)H oxidase-dependent superoxide generation during acute stage of subarachnoid hemorrhage in rat pial artery. J Cereb Blood Flow Metab 22 (2002) 869-877
164. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276 (2001) 1417-1423
165. Silacci P., Desgeorges A., Mazzolai L., Chambaz C., and Hayoz D. Flow pulsatility is a critical determinant of oxidative stress in endothelial cells. Hypertension 38 (2001) 1162-1166
166. Sobey C.G., and Faraci F.M. Subarachnoid haemorrhage: what happens to the cerebral arteries?. Clin Exp Pharmacol Physiol 25 (1998) 867-876
167. + channels. Stroke 28
168. Sobey C.G., Heistad D.D., and Faraci F.M. Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am J Physiol 275 (1998) H1606-H1612
169. Sokoloff L. Anatomy of Cerebral Circulation (1997), Academic Press, London
170. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
171. 2 is mediated through tyrosine kinsase-dependent, PKC-independent pathways in vascular smooth muscle cells-upregulation in SHR. J Hypertens 23 (2005) 2005-2012
172. Takeya R., Ueno N., Kami K., Taura M., Kohjima M., Izaki T., et al. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 278 (2003) 25234-25246
173. Tanaka K., Fujimoto Y., Suzuki M., Suzuki Y., Ohtake T., Saito H., et al. PI3-kinase p85alpha is a target molecule of proline-rich antimicrobial peptide to suppress proliferation of ras-transformed cells. Jpn J Cancer Res 92 (2001) 959-967
174. Teunissen L.L., Rinkel G.J., Algra A., and van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 27 (1996) 544-549
175. Thomas S.R., Chen K., and Keaney Jr. J.F. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277 (2002) 6017-6024
176. 2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys 319 (1995) 491-497
177. Tosaka M., Hashiba Y., Saito N., Imai H., Shimizu T., and Sasaki T. Contractile responses to reactive oxygen species in the canine basilar artery in vitro: selective inhibitory effect of MCI-186, a new hydroxyl radical scavenger. Acta Neurochir (Wien) 144 (2002) 1305-1310
178. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 44 (2004) 248-252
179. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90 (2002) 1205-1213
180. Touyz R.M., Tabet F., and Schiffrin E.L. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 30 (2003) 860-866
181. Touyz R.M., Mercure C., He Y., Javeshghani D., Yao G., Callera G.E., et al. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 45 (2005) 530-537
182. Tsunawaki S., Kagara S., Yoshikawa K., Yoshida L.S., Kuratsuji T., and Namiki H. Involvement of p40phox in activation of phagocyte NADPH oxidase through association of its carboxyl-terminal, but not its amino-terminal, with p67phox. J Exp Med 184 (1996) 893-902
183. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
184. Ullegaddi R., Powers H.J., and Gariballa S.E. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr 59 (2005) 1367-1373
185. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., and Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271 (1996) 23317-23321
186. Vallet P., Charnay Y., Steger K., Ogier-Denis E., Kovari E., Herrmann F., et al. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132 (2005) 233-238
187. Virdis A., Neves M.F., Amiri F., Touyz R.M., and Schiffrin E.L. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22 (2004) 535-542
188. Wagner A.H., Kohler T., Ruckschloss U., Just I., and Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20 (2000) 61-69
189. Walder C.E., Green S.P., Darbonne W.C., Mathias J., Rae J., Dinauer M.C., et al. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28 (1997) 2252-2258
190. Wang G., Anrather J., Huang J., Speth R.C., Pickel V.M., and Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24 (2004) 5516-5524
191. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99 (1999) 2027-2033
192. Watanabe Y., Chu Y., Andresen J.J., Nakane H., Faraci F.M., and Heistad D.D. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 34 (2003) 434-440
193. 2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine. Hypertension 16 (1990) 162-169
194. Wei E.P., Christman C.W., Kontos H.A., and Povlishock J.T. Effects of oxygen radicals on cerebral arterioles. Am J Physiol 248 (1985) H157-H162
195. Wei E.P., Kontos H.A., and Beckman J.S. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol 271 (1996) H1262-H1266
196. Wolin M.S., Burke-Wolin T.M., and Mohazzab H.K. Roles for NAD(P)H oxidases and reactive oxygen species in vascular oxygen sensing mechanisms. Respir Physiol 115 (1999) 229-238
197. Wolin M.S., Ahmad M., and Gupte S.A. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 289 (2005) L159-L173
198. 2+ sparks. Circ Res 97 (2005) 354-362
199. Yan C., Huang A., Wu Z., Kaminski P.M., Wolin M.S., Hintze T.H., et al. Increased superoxide leads to decreased flow-induced dilation in resistance arteries of Mn-SOD-deficient mice. Am J Physiol Heart Circ Physiol 288 (2005) H2225-H2231
200. Yang S.T., Mayhan W.G., Faraci F.M., and Heistad D.D. Mechanisms of impaired endothelium-dependent cerebral vasodilatation in response to bradykinin in hypertensive rats. Stroke 22 (1991) 1177-1182
201. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25 (1994) 165-170
202. Yang Z.W., Zhang A., Altura B.T., and Altura B.M. Endothelium-dependent relaxation to hydrogen peroxide in canine basilar artery: a potential new cerebral dilator mechanism. Brain Res Bull 47 (1998) 257-263
203. You J., Golding E.M., and Bryan Jr. R.M. Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries. Am J Physiol Heart Circ Physiol 289 (2005) H1077-H1083
204. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32 (1998) 488-495
205. Zalba G., San Jose G., Moreno M.U., Fortuno M.A., Fortuno A., Beaumont F.J., et al. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38 (2001) 1395-1399
206. Zheng J.S., Zhan R.Y., Zheng S.S., Zhou Y.Q., Tong Y., and Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke 36 (2005) 1059-1064
207. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91 (2002) 1038-1045
208. Zimmerman M.C., Dunlay R.P., Lazartigues E., Zhang Y., Sharma R.V., Engelhardt J.F., et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95 (2004) 532-539